TASK DEFINITION: Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.
PROBLEM: She's disappointed not to have been able to claim ultimate victory in the battle against the human immunodeficiency virus (HIV) that causes the killer disease AIDS, but also proud that in three decades, the virus has been beaten into check. While a cure for AIDS may or may not be found in her lifetime, the 68-year-old says, achieving "remission" - where infected patients control HIV in their bodies and, crucially, can come off treatment for years - is definitely within reach. "I am personally convinced that remission...is achievable. When? I don't know. But it is feasible," she told Reuters at her laboratory at Paris's Pasteur Institute, where she and her mentor Luc Montagnier discovered HIV in 1983. "We have 'proof of concept'. We have...the famous Visconti patients, treated very early on. Now it is more than 10 years since they stopped their treatment and they are still doing very well, most of them." Sinoussi is referring to a study group of 14 French patients known as the Visconti cohort, who started on antiretroviral treatment within 10 weeks of being infected and stayed on it for an average of three years. A decade after stopping the drugs, the majority have levels of HIV so low they are undetectable. These and other isolated cases of remission, or so-called "functional cure", give hope to the 37 million people worldwide who, due to scientific progress, should now be able to live with, not have their lives cut short by, HIV. In developed countries at least - and in many poorer ones too - an HIV positive diagnosis is no longer an immediate death sentence, since patients can enjoy long, productive lives in decent health by taking antiretroviral drugs to control the virus. It's a long way from the early 1980s, when Sinoussi remembers sick, dying HIV-positive patients coming to the doors of the Pasteur and pleading with scientists there for answers. "They asked us: 'What we are going to do to cure us'," she says. At that time, she says, she knew relatively little about HIV, but what she was sure of was that these patients would never live long enough to see a treatment developed, let alone a cure. "It was very, very hard." Yet this interaction with real patients, and with their doctors and later their advocates, gave Sinoussi an important insight into what was needed to make her life in science one with meaning and impact collaboration. Working across barriers - be they scientific disciplines, cultural, religious and political divides, international borders or gender distinctions, has been and remains Sinoussi's driving force. In her earliest days, feeling disengaged while working on her PhD and itching for action in a real-life laboratory, she hustled her way in to working at the male-dominated Pasteur Institute for free with a virologist researching links between cancers and retroviruses in mice. While viruses are her thing, she has throughout her career worked with, cajoled and learned from immunologists, cancer specialists, experts in diseases of aging, pharmaceutical companies, AIDS patients, campaigners, and even the pope. "When you work in HIV, it's not only working in HIV, it's working far, far beyond," she said. Freshly armed with her Nobel award and fired up about a lack of support for proven methods of preventing HIV's spread, Sinoussi wrote an open letter to then-Pope Benedict XVI in 2009 criticising him for saying that condoms can promote the spread of AIDS. In what was widely seen as a modification of his stance in response to such criticism, Benedict said in a book a year later that use of condoms could sometimes be justified in certain limited cases as a way to fight AIDS. Sinoussi says: "HIV has shown the way to go in the field of science. You can't be isolated in your laboratory. You need to work with others." And this, she adds, is the "all together" spirit with which she advises her successors to continue after she's gone. Many will be sad to see her leave, but she has faith that her chosen field will deliver for the people who need it. "Of course, I would love to have stopped and to see we had a vaccine against HIV and another treatment that could induce remission but that's life. I encourage the new generation of scientists today to continue our work. "Science never stops," she says. "Just because a scientist stops, the science should not stop."

SOLUTION: Science won't stop until it beats AIDS, says HIV pioneer.

PROBLEM: The decision by Dewayne Johnson, who sued Monsanto in 2016, brings the total award to $78 million, down from the jury's verdict on Aug. 10 of $289 million - $39 million in compensatory and $250 million in punitive damages. Johnson's law firm said in a statement that he accepted the reduction "to hopefully achieve a final resolution within his lifetime." Judge Suzanne Bolanos of San Francisco's Superior Court of California, who oversaw the trial, earlier this month affirmed the liability portion of the verdict, but ordered punitive damages to be slashed to concur with California and federal law. Bayer denies allegations that glyphosate can cause cancer and said it will appeal the decision as the verdict was not supported by the evidence presented at trial. The verdict, which marked the first such decision against Monsanto, wiped 10 percent off the value of the company and shares have since dropped nearly 30 percent from their pre-verdict value. The company, which faces more than 8,700 U.S. lawsuits over glyphosate, says decades of scientific studies and real-world use have shown glyphosate to be safe for human use. Regulators around the world, including the U.S. Environmental Protection Agency, have found glyphosate was not a likely carcinogen to humans and approved the chemical, but the cancer unit of the World Health Organization in 2015 classified glyphosate as "probably carcinogenic to humans." The jury found the company's glyphosate-containing RoundUp and Ranger Pro products responsible for causing Johnson's non-Hodgkin's lymphoma and said the company had failed to warn him and other consumers of the risks. Johnson could decide whether to accept the reduction or face a new trial on the punitive damages portion. His lawyers on Wednesday said they would challenge the amount of damages during Bayer's appeal.

SOLUTION: Groundskeeper in Bayer in U.S. weed-killer case accepts reduced award.

PROBLEM: Jahi McMath, 13, was taken by a private ambulance on Sunday night from Children's Hospital and Research Center in Oakland to a long-term care facility where she will be given a tracheostomy and feeding tube, uncle Omari Sealey said. "The goal is for them (the new center) is to give her treatment to help her get to full recovery," Sealey said. McMath was admitted to Children's Hospital on December 9 to have her tonsils removed as well as other procedures performed in an effort to treat her sleep apnea. After the surgery, the girl began to bleed profusely, went into cardiac arrest and suffered brain swelling. The hospital declared her brain dead three days later and made plans to remove her from a ventilator. But her family has fought in state and federal court to keep her on life support. A restraining order barring the hospital from removing that life support had been set to expire on Tuesday. The case has drawn international attention, as well as support from relatives of Terri Schiavo, a Florida woman who died in 2005 after a 15-year battle over whether to keep her body alive in a persistent vegetative state. An extended-care facility on New York's Long Island, the New Beginnings Community Center, has offered to care for the child. But it was not immediately clear if McMath's family had accepted the offer. Sealey said on Monday that the Long Island facility was among dozens willing to admit his niece, but declined to disclose what facility had taken her in, saying the family had received threats of violence since McMath's story became public. Physicians at the new care center planned to perform surgeries on the girl, including a tracheostomy and gastrostomy for breathing and feeding, Sealey said. McMath has not been fed since the day before she was admitted to Children's Hospital four weeks ago, and nutrients would be needed for any rehabilitation, he added. McMath's lungs are continuing to function because of air being forced in and out by a ventilator, without which her breathing and heartbeat would cease, according to medical experts. Unlike a person in a coma, McMath lacks brain activity that would allow her to breathe on her own, doctors have said. Sealey said initial doctors' exams of McMath since her transfer showed some possible brain activity. "They feel like she is not completely gone," he said. Children's Hospital has said that McMath's brain death was tragic but irreversible. Hospital officials have said the facility and state health officials are investigating how a routine operation led to McMath's condition.

SOLUTION:
Brain-dead California girl arrives at extended care facility.